Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects
- Study Title
- Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects
- Teva Identifier
- C26401/1111 | 2013-001883-51
- ClinicalTrials.gov Identifier
- NCT01903824
- Study Status
- Completed
- Trial Condition(s)
- Cognitive Impairment
- Interventions
- Drug: CEP-26401 | Drug: donepezil hydrochloride | Drug: modafinil | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 50 Years
- Trial Duration
- 08/01/2013 - 12/01/2013
- Phase
- Phase 1
